Stent-graft system to treat the complex abdominal aortic aneurisms (AAA). Stent-graft is designed to allow high flexibility and wall apposition while maintaining patency. Landing zone ~ 10mm, and the maximum infrarenal artery angulation is 75°.
Stent-graft system to treat thoracic aortic aneurysms and dissections. Stent-graft is designed to allow high flexibility
and wall apposition while maintaining patency.
Landing zone ~ 10mm.
MemoPart™ PFO Occluder is a percutaneous, transcatheter device used to close Patent Foramen Ovale defect in patients at risk for ischemic stroke.
MemoPart™ ASD Occluder is a percutaneous, transcatheter device used to close Atrial Septal Defects.
MemoPart™ PDA Occluder is a percutaneous, transcatheter device used to close Patent Ducts Arterious.
TricValve®–Transcatheter Bicaval Valves System is a system of two self-expanding biological valves for the treatment of patients with hemodynamically relevant tricuspid insufficiency and caval reflux. The prostheses are implanted percutaneously into the superior and inferior vena cava without disturbing the native tricuspid valve. It is especially intended for use for patients at extreme risk or who are inoperable for open surgical therapy.
BALMED designs and manages sales channels in Italy, Poland, and Switzerland.
The sales are fully customized to the innovator’s needs.
Our business model ensures avoiding conflicts of interest, enabling our Team to a maximum dedication and promotion efficacy to meet pre-defined objectives.
For over 40 years, Balton has been combining clinical experience with precision of workmanship of the advanced disposable medical devices, empowering healthcare professionals in their every-day work.
Lepu Medical Technology (Beijing) Co., Ltd. was established in 1999. Lepu Medical is specialized in developing, manufacturing and distributing the high-tech medical devices and equipment.
In 2009, Lepu Medical went public in ChiNext Shenzhen Stock Exchange market (stock code: 300003). Now Lepu Medical totally has 28 primary subsidiary companies worldwide. Currently, there are 119 products have received the CE certificates, and 11 products have got the FDA approvals. As the National Interventional Cardiology Medical Instruments & Engineering Technology Research Center, Lepu Medical Group’s top strategy is to build up a 4 in 1 platform includes medical devices, medicines, health services and mobile medicals for cardiac treatments. Lepu Medical has established three overseas subsidiary companies in Netherland, Turkey and India, obtained local registrations in 27 countries, and built the sales and distribution channels in over 80 countries and regions.
Lepu Medical upholds “integrity, quality and scientific innovation” as its spirit, commitments to provide the best quality of products and services to satisfy the needs of healthcare professionals and patients.
BALMED S.r.l. is the exclusive distributor of Lepu Medical Technology (Beijing) Co., Ltd. structural heart subsidiary namely Shanghai Shape Memory Alloy Co. Ltd for the following regions in Italy: Lombardy, Triveneto, Abruzzo, Campania (partially) and Sicily.
Merlin MD is redefining cerebral stroke treatment. Its patented membrane system provides a unique platform for flow-diversion that’s effective in Hemorrhagic treatment and in clot entrapment for Ischemic stroke treatment.
Merlin MD today envisions a future where Ischemic and Hemorrhagic strokes can be addressed swiftly, effectively, and comprehensively.
With technology produced and manufactured in Singapore, Asia’s tech hub, precision, quality and trustworthiness is guaranteed.
BALMED S.r.l. is the exclusive distributor of Merlin MD in Italy.
Percutek Therapeutics is an R&D and manufacturing company providing aortic endoprosthesis for TEVAR, EVAR, and other aortic therapies.
BALMED S.r.l. is the exclusive distributor of Beijing Percutek Therapeutics Inc. in Italy.
Shanghai Pulse Medical Technology Inc., founded in 2015, located in Shanghai, China, is dedicated to develop innovative technology for precise diagnosis and optimal treatment of patients with pan-vascular disease.
Together with our R&D partners, eg., Shanghai Jiao Tong University, Fuwai Hospital CAMS (Chinese Academy of Medical Sciences), Zhongshan Hospital affiliated to Fudan University, Oxford University, Aarhus University Hospital, Pulse Medical has been pioneering invented the key algorithm of quantitative flow ratio (QFR), the fast computation methodology of fractional flow reserve (FFR) from multiple imaging data.
The computed tomography based FFR (CT-QFR), angiography-based FFR solution (QFR in first generation, μFR in 2nd generation) and intracoronary IVUS or OCT based
FFR (UFR, OFR) are commercialized already in certain geographies.
Pulse Medical mission is to deliver the innovative and valuable solutions to improve patient outcomes.
BALMED S.r.l. is the exclusive distributor of Shanghai Pulse Medical Technology Inc in Italy.
P+F Products + Features GmbH is a medical technology company focused on research, development, and manufacture of innovative minimally invasive solutions in the field of cardiology.
Our R&D capabilities are the foundation of our approach to innovation while developing new products and enhancing existing ones; our purpose is to leverage these capabilities to generate distinctive value and expand access to state-of-the-art technology for patients and healthcare providers worldwide.
Having more than 25 years of experience in the medical field, the leadership team of P+F has built up a complete infrastructure for research, development, manufacture, and distribution in order to deliver significant innovations and add economic value to its customers.
P+F is headquartered in Vienna, Austria, and has operation facilities in Germany, Portugal, Spain, and Brazil.
BALMED S.r.l. is the exclusive distributor of Products and Features GmbH in Poland.
The Leadership Team here at INFINTY-NEURO has a combined 50+ years of experience in the Medical Device Industry. All of our team members have built outstanding careers in every facet of the business including the development, marketing, research, engineering and commercialization of ground breaking, innovative patented Medical Devices.
Their decades of experience has afforded them the ability to build longstanding relationships with physicians, surgeons, medical and business professionals worldwide. These relationships are an integral part of the success of INFINTY-NEURO.
The INFINTY-NEURO team has an established history with proven success at developing neurovascular devices, gaining regulatory approvals worldwide and achieving thriving product launches. Company location: 105 N. Pointe Drive, Ste. A Lake Forest, CA. 92630, USA.
BALMED S.r.l. is the exclusive distributor of Infinity Neuro in Italy.